Resonetics
Private Company
Total funding raised: $100M
Overview
Resonetics is a privately held, Switzerland-headquartered company with principal operations in Nashua, New Hampshire, USA, founded in 1987. It operates as a specialized contract development and manufacturing organization (CDMO) and engineering services partner for the medical technology sector. The company's value proposition centers on accelerating time-to-market for clients through its vertically integrated Nitinol supply chain, rapid prototyping 'Lightspeed Labs,' and a broad portfolio of micro-manufacturing capabilities. With 18 global facilities and a focus on interventional, advanced surgery, diagnostics, and bioelectronics markets, Resonetics provides end-to-end support from concept to high-volume manufacturing.
Technology Platform
Vertically integrated Nitinol (Melt to Market™) processing, micro-manufacturing (laser processing, microfluidic laminates, sensor integration), and a global network of rapid prototyping facilities (Lightspeed Labs).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Resonetics competes with large, diversified contract manufacturers (e.g., Flex, Jabil) and specialized medical device CDMOs (e.g., Integer Holdings, Teleflex OEM). Its primary differentiation is its deep, vertically integrated expertise in Nitinol and a strong focus on micro-manufacturing and rapid prototyping for the medical sector, offering a blend of material science and engineering services.